title: Inflammatory mediators induce sequestration of VE-cadherin in cultured human endothelial cells.
abstract: The mechanisms through which inflammatory mediators modify endothelial junctional structure are not well understood. Endothelial cells exposed to 1 mM H2O2, 0.1 mM histamine or 4 mM EDTA displayed decreased amounts of VE-cadherin on the cell surface in a time-dependent manner. H2O2 and EDTA-treated cells showed a sustained reduction in surface VE-cadherin, but histamine (0.1 mM) decreased cell surface VE-cadherin only at 5 and 15 min, not at 30 and 60 min. Sequestering of VE-cadherin could also be visualized as a decrease in immunofluorescent labeling of endothelial junctions in fixed, non-extracted monolayers. However, junctional staining was observed in these cells after membrane extraction. This decreased surface expression of VE-cadherin was actin-filament, but not PKC/MAP kinase dependent. VE-cadherin binding to the cytoskeleton was decreased by EDTA, but was not diminished by histamine or H2O2. Therefore, by promoting sequestration of junctional cadherins, inflammatory mediators may decrease adhesive bonds between apposed endothelial cells and increase solute permeability.
authors.affiliation: Molecular and Cellular Physiology, LSU Medical Center, Shreveport, Louisiana 71130, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Alexander
authors.forename: B C
authors.initials: BC
authors.lastname: Alexander
authors.forename: L A
authors.initials: LA
authors.lastname: Eppihimer
authors.forename: N
authors.initials: N
authors.lastname: Goodyear
authors.forename: R
authors.initials: R
authors.lastname: Haque
authors.forename: C P
authors.initials: CP
authors.lastname: Davis
authors.forename: T J
authors.initials: TJ
authors.lastname: Kalogeris
authors.forename: D L
authors.initials: DL
authors.lastname: Carden
authors.forename: Y N
authors.initials: YN
authors.lastname: Zhu
authors.forename: C G
authors.initials: CG
authors.lastname: Kevil
mesh_terms: D015703:Antigens, CD; D015820:Cadherins / Q000187:drug effects* / Q000378:metabolism*; D002227:Carbazoles / Q000494:pharmacology; D002478:Cells, Cultured / Q000737:chemistry; D015638:Cytochalasin D / Q000494:pharmacology; D003599:Cytoskeleton / Q000378:metabolism; D004492:Edetic Acid / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005419:Flavonoids / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D018836:Inflammation Mediators / Q000494:pharmacology*; D008565:Membrane Proteins / Q000378:metabolism; D011485:Protein Binding; D013997:Time Factors; D014471:Umbilical Veins / Q000166:cytology; D000099152:Cadherin 5
chemical_list: D015703:Antigens, CD; D015820:Cadherins; D002227:Carbazoles; D015638:Cytochalasin D; D004492:Edetic Acid; D004791:Enzyme Inhibitors; D005419:Flavonoids; D006632:Histamine; D006861:Hydrogen Peroxide; D007211:Indoles; D018836:Inflammation Mediators; D008565:Membrane Proteins; D000099152:Cadherin 5; C081021:Go 6976; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one